Novartis Ag (NVS) Goodwill (2009 - 2026)

Novartis Ag (NVS) has 12 years of Goodwill data on file, last reported at $1.4 billion in Q1 2026.

• Quarterly Goodwill changed N/A year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (changed N/A YoY) and the FY2025 annual result came in at $25.6 billion, up 3.28% from the prior year.
• Goodwill eased to $1.4 billion in Q1 2026 per NVS's latest filing, from $25.6 billion in the prior quarter.
• The five-year high for Goodwill was $29.5 billion in Q2 2023, with the low at $148.0 million in Q1 2022.
• Average Goodwill over 5 years is $16.8 billion, with a median of $24.8 billion recorded in 2024.
• The widest YoY moves for Goodwill: up 18011.66% in 2023, down 20.34% in 2023.
• Novartis Ag's Goodwill stood at $29.3 billion in 2022, then retreated by 20.34% to $23.3 billion in 2023, then rose by 6.06% to $24.8 billion in 2024, then increased by 3.28% to $25.6 billion in 2025, then tumbled by 94.52% to $1.4 billion in 2026.
• Business Quant data shows NVS's Goodwill at $1.4 billion in Q1 2026, $25.6 billion in Q4 2025, and $25.6 billion in Q2 2025.